Blaise Lippa

Blaise Lippa is a seasoned professional in the biotech and pharmaceutical industries, currently serving as CXO at Curie.Bio and Principal at Blaise Consulting LLC, providing consulting services in biotech company creation, strategic planning, and drug design. Lippa holds significant experience as a member of the Scientific Advisory Board at ProteinQure and has previously served as Chief Scientific Officer at Morphic Therapeutic, where leadership encompassed research and translational sciences across multiple therapeutic areas. Prior roles include Sr. Vice President of Molecular Discovery and Vice President of Chemistry at Morphic Therapeutic and Senior Director of Medicinal Chemistry at Cubist Pharmaceuticals, leading diverse teams and projects aimed at clinical advancement. Education includes a Ph.D. in Organic Chemistry from Stanford University and a B.S. in Chemistry and Cellular Molecular Biology from the University of Michigan.